UK SPCs to return, but for second medical uses?
Skating on thin ice: the Valieva doping saga and regulatory implications
Artistic control or market manipulation?
Consumer and retail in the news
Court of Appeal in Ireland grants interlocutory injunction restraining the launch of Teva’s generic apixaban product pending determination of appeal
Commission accuses Alchem of cartel involvement in pharmaceutical sector